These effects, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 support the principle of focusing on ACKR3 as a unique technique to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Diseases. The health supplement is built https://tuckerv061vlh0.loginblogin.com/profile